CD4+ T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses

Bruce R Blazar, Patricia A Taylor, Randolph J. Noelle, Daniel A Vallera

Research output: Contribution to journalArticlepeer-review

84 Scopus citations

Fingerprint

Dive into the research topics of 'CD4<sup>+</sup> T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses'. Together they form a unique fingerprint.

Medicine & Life Sciences